‹ ›
MYP_102456
← PREVIOUS NEXT → BACK
Basic Information
Unnamed
Antimicrobial
Antiviral
Immunology ▸ Immune modulation ▸ Immunomodulatory activity
Standard
9 amino acids
C48H76N10O17S2
Standard
Sequence
SMIENLEYM
Physicochemical Analysis
1129.30 Da
4.05
-2.54
-2.75
-0.2817
-0.06
0.38
0.17
106.53
86.67
0.1111
1490.00
1490.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
454.27
-2.58
15.0
17.0
38.0
77.0
1.0
9.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0072179 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Antimicrobial
PaperAVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses (https://pubmed.ncbi.nlm.nih.gov/24285301/) PMID24285301 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24285301/
RECORD: Rec_0275948 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Immunomodulatory
Lymphocytic choriomeningitis virus (CTL lysis); MC57
50 μM
Cytotoxicity
PaperDesign of high-affinity major histocompatibility complex-specific antagonist peptides that inhibit cytotoxic T-lymphocyte activity: implications for control of viral disease. | Gairin JE, Oldstone MB. | J Virol. 1992 | PMID:1383569 PMID1383569 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/1383569/